The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting serum response factor as a novel therapeutic approach for triple-negative breast cancer.
 
Maria Prencipe
No Relationships to Disclose
 
Claudia Aura Gonzalez
No Relationships to Disclose
 
Niamh Russell
No Relationships to Disclose
 
William M. Gallagher
Employment - OncoMark
Leadership - OncoMark
Stock and Other Ownership Interests - OncoMark
Consulting or Advisory Role - Carrick Therapeutics
Research Funding - Carrick Therapeutics
Patents, Royalties, Other Intellectual Property - Two patents which have been licenced to OncoMark Limited
Travel, Accommodations, Expenses - OncoMark
 
John Crown
Honoraria - Amgen; Boehringer Ingelheim; Eisai; Genomic Health; Pfizer; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - Eisai; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; MSD; Pfizer; Roche